相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。O6-Methylguanine-DNA Methyltransferase (MGMT): Challenges and New Opportunities in Glioma Chemotherapy
Wei Yu et al.
FRONTIERS IN ONCOLOGY (2020)
Small molecule tyrosine kinase inhibitors in glioblastoma
Gayoung Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2020)
The role of diffusion tractography in refining glial tumor resection
Davy Charles Vanderweyen et al.
BRAIN STRUCTURE & FUNCTION (2020)
Inhibition of NF-κB-Dependent Signaling Enhances Sensitivity and Overcomes Resistance to BET Inhibition in Uveal Melanoma
Grazia Ambrosini et al.
CANCER RESEARCH (2019)
Author Correction: Macrophages confer resistance to PI3K inhibitor GDC-0941 in breast cancer through the activation of NF-κB signaling (vol 9, 809, 2018)
Muhammad Waqas Usman et al.
CELL DEATH & DISEASE (2019)
Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme
Zhenzhe Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Fstl1/DIP2A/MGMT signaling pathway plays important roles in temozolomide resistance in glioblastoma
Er Nie et al.
ONCOGENE (2019)
Temozolomide and Other Alkylating Agents in Glioblastoma Therapy
Hannah Strobel et al.
BIOMEDICINES (2019)
Hyaluronan and proteoglycan link protein 1 (HAPLN1) activates bortezomib-resistant NF-κB activity and increases drug resistance in multiple myeloma
Mailee Huynh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Advances in immunotherapeutic research for glioma therapy
Jeremy Tetsuo Miyauchi et al.
JOURNAL OF NEUROLOGY (2018)
Glioma epigenetics: From subclassification to novel treatment options
Olga Gusyatiner et al.
SEMINARS IN CANCER BIOLOGY (2018)
RIP2 enhances cell survival by activation of NF-κB in triple negative breast cancer cells
Rola Jaafar et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Inhibition of NF-kappa B results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression
Zhiyun Yu et al.
CANCER LETTERS (2018)
Novel approach to temozolomide resistance in malignant glioma: connexin43-directed therapeutics
Christina L. Grek et al.
CURRENT OPINION IN PHARMACOLOGY (2018)
Transcriptional control of O6-methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma
Caroline Happold et al.
JOURNAL OF NEUROCHEMISTRY (2018)
Long noncoding RNA DANCR mediates cisplatin resistance in glioma cells via activating AXL/PI3K/Akt/NF-κB signaling pathway
Yangang Ma et al.
NEUROCHEMISTRY INTERNATIONAL (2018)
Perfluorooctanoic acid stimulates ovarian cancer cell migration, invasion via ERK/NF-κB/MMP-2/-9 pathway
Xiaozhao Li et al.
TOXICOLOGY LETTERS (2018)
CAT3, a prodrug of 13a(S)-3-hydroxyl-6,7-dimethoxyphenanthro[9, 10-b]-indolizidine, circumvents temozolomide-resistant glioblastoma via the Hedgehog signaling pathway, independently of O6-methylguanine DNA methyltransferase expression
Ming Ji et al.
ONCOTARGETS AND THERAPY (2018)
Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma
Shabierjiang Jiapaer et al.
NEUROLOGIA MEDICO-CHIRURGICA (2018)
A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma
Xiaoyue Chen et al.
NATURE COMMUNICATIONS (2018)
Structural basis of RIP2 activation and signaling
Qin Gong et al.
NATURE COMMUNICATIONS (2018)
NFκBP65 transcription factor modulates resistance to doxorubicin through ABC transporters in breast cancer
Kobra Velaei et al.
BREAST CANCER (2017)
PAX5 interacts with RIP2 to promote NF-κB activation and drug-resistance in B-lymphoproliferative disorders
Dong Wang et al.
JOURNAL OF CELL SCIENCE (2016)
NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer
A. R. Ozes et al.
ONCOGENE (2016)
Temozolomide resistance in glioblastoma multiforme
Sang Y. Lee
GENES & DISEASES (2016)
Primary spinal cord glioblastoma multiforme treated with temozolomide
Silvia Hernandez-Duran et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2015)
NF-κB inhibitor reverses temozolomide resistance in human glioma TR/U251 cells
Xuan Wang et al.
ONCOLOGY LETTERS (2015)
Glioma
Michael Weller et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Current and Investigational Drug Strategies for Glioblastoma
M. Ajaz et al.
CLINICAL ONCOLOGY (2014)
Role of Rip2 in Development of Tumor-Infiltrating MDSCs and Bladder Cancer Metastasis
Hanwei Zhang et al.
PLOS ONE (2014)
Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways
Stina M. Singel et al.
BREAST CANCER RESEARCH (2014)
NF-κB Regulates Radioresistance Mediated By β1-Integrin in Three-Dimensional Culture of Breast Cancer Cells
Kazi Mokim Ahmed et al.
CANCER RESEARCH (2013)
O6-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas
C-H Fan et al.
CELL DEATH & DISEASE (2013)
Enhanced stability and activity of temozolomide in primary glioblastoma multiforme cells with cucurbit[n]uril
Eric A. Appel et al.
CHEMICAL COMMUNICATIONS (2012)
O6-(4-bromothenyl)guanine reverses temozolomide resistance in human breast tumour MCF-7 cells and xenografts
M Clemons et al.
BRITISH JOURNAL OF CANCER (2005)
Inhibitory action of novel aromatic diamine compound on lipopolysaccharide-induced nuclear translocation of NF-κB without affecting IκB degradation
HM Shin et al.
FEBS LETTERS (2004)
分享论文
